[Reappraisal of the value of CD30 testing in the diagnosis and treatment of lymphoma].

Zhao RR, Fu Y, Fan XS

Open source

DOI
10.3760/cma.j.cn112151-20260409-00259
Published
2026 Nov 8
Container
Zhonghua bing li xue za zhi = Chinese journal of pathology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3760/cma.j.cn112151-20260409-00259,
  title = {[Reappraisal of the value of CD30 testing in the diagnosis and treatment of lymphoma].},
  author = {Zhao RR and Fu Y and Fan XS},
  year = {2026},
  journal = {Zhonghua bing li xue za zhi = Chinese journal of pathology},
  doi = {10.3760/cma.j.cn112151-20260409-00259},
  url = {https://doi.org/10.3760/cma.j.cn112151-20260409-00259}
}

RIS

TY  - JOUR
TI  - [Reappraisal of the value of CD30 testing in the diagnosis and treatment of lymphoma].
AU  - Zhao RR
AU  - Fu Y
AU  - Fan XS
PY  - 2026
JO  - Zhonghua bing li xue za zhi = Chinese journal of pathology
DO  - 10.3760/cma.j.cn112151-20260409-00259
UR  - https://doi.org/10.3760/cma.j.cn112151-20260409-00259
ER  - 

APA

RR, Z., Y, F., & XS, F. (2026). [Reappraisal of the value of CD30 testing in the diagnosis and treatment of lymphoma].. Zhonghua bing li xue za zhi = Chinese journal of pathology. https://doi.org/10.3760/cma.j.cn112151-20260409-00259

Source records